You searched for "disease"
World Optometry Day 2022
23 March 2022
| Janet Pooley
Today, Wednesday 23rd March, is #WorldOptometryDay. A day to celebrate the global community of optometrists and all the eye care professionals that support the ophthalmic health and wellbeing of many millions of patients.
Eye research: where next?
1 December 2017
| Rod McNeil
|
Cornea / External Eye Disease, Cataract and Refractive, Glaucoma, Genetics, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Ophthalmology, Optometry, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous, AMD, Emergency Ophthalmology
Eye research in the UK is underfunded relative to other areas of medical research and general awareness of sight loss and its prevention remains poor, messages that were reinforced in presentations and discussions during a recent research summit meeting in...
All eyes on Twiggy as she fronts new campaign warning us: don’t lose focus of your eye health
13 October 2022
Dame Twiggy Lawson fronts a new public awareness campaign focused on eye health, as cases of macular disease increase with our ageing population.
Case series of posterior scleritis
1 October 2014
| Saruban Pasu
|
Ocular Pathology and Oncology
|
Scleritis, Ocular inflammatory disease, Inflammation, Sclera
This report aimed to facilitate the correct diagnosis of posterior scleritis, a condition which is usually overlooked or misdiagnosed. Electronic health records of 31 patients with posterior scleritis were analysed and compared to a group with isolated anterior scleritis of...
Corporate M&A pace gathers momentum
1 October 2019
| Rod McNeil
|
AMD, Cataract and Refractive, Cornea / External Eye Disease, Emergency Ophthalmology, Genetics, Glaucoma, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Ophthalmology, Optometry, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous
Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...
How do you solve the problem of trachoma in Ethiopia?
4 October 2023
| Alemayehu Sisay
|
EYE - Cornea
Background Trachoma is one of the oldest diseases known to humankind and the leading infectious cause of blindness worldwide. Spread by the bacterium chlamydia trachomatis, it is transmitted through contact with the eyes, eyelids and nose of those infected. The...
Neurofibromatosis type 2 – diagnosis, features and MDT approach
1 December 2021
| Jincy Kurian
|
Ophthalmology, Orbit, Retina / Uvea / Vitreous, Cataract and Refractive
NF2 is a genetic condition caused by mutation in a single gene (NF2 gene) on chromosome 22. The NF2 gene provides instructions to produce a protein called merlin, also known as schwannomin. This protein functions as a tumour suppressor, preventing...
Nanoparticle administration of latanoprost
1 December 2013
| Graham Wallace
|
Glaucoma
Glaucoma is a progressive optic neuropathy characterised by increased ocular pressure and loss of retinal ganglion cells. Conventional drug therapy with eye drops to reduce intraocular pressure (IOP) has variable bioavailability and can lead to ocular surface disease. In this...
In conversation with Robert MacLaren
2 December 2019
|
Ophthalmology, EYE - Vitreo-Retinal
Professor Robert MacLaren gave the Keeler Lecture at the Royal College of Ophthalmologists Annual Meeting in May 2019 on gene therapy for retinitis pigmentosa. We caught up with him afterwards to find out more. What are the key messages of...
Macular Society chief executive, Cathy Yelf, announces retirement
After nearly a decade of dedicated service as chief executive of leading sight loss charity the Macular Society, Cathy Yelf has announced her decision to retire in 2024.Beliefs and adherence to glaucoma treatment
1 October 2014
| Lorraine North
|
Glaucoma
The aim of the study was to determine adherence rates and beliefs about glaucoma and its treatment in white Americans, African Americans, white Australians and Singaporeans of Chinese descent. A cross-sectional study of 475 glaucoma patients using topical eye drops...